ArticleInternational journal of nanomedicine2017

Surface-modified gatifloxacin nanoparticles with potential for treating central nervous system tuberculosis.

Patricia Marcianes et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.